Braskem S.A. reported a Recurrent EBITDA of US$1.1 billion for 2024, a 46% increase from 2023, driven by higher resin and chemical sales, alongside operational improvements. The company also projected spending US$484 million on investments in 2025 to optimize its asset portfolio amid challenging market conditions and legal proceedings related to geological issues in Alagoas.